High up-front costs could delay access to life-saving blood cancer drugs for Medicare patients

(UNC Lineberger Comprehensive Cancer Center) Researchers from the UNC Lineberger Comprehensive Cancer Center and collaborators report that nearly a third of a group of patients with chronic myeloid leukemia, and who have Medicare prescription drug insurance, did not start treatment within six months of diagnosis with any of three targeted drugs that have led to dramatic improvements in survival for the disease.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news